Adenoviral gene expression and replication in human tumor explant models

Methods in Molecular Biology

Volumn 797, Issue , 2012, Pages 65-78

  Halldén, Gunnel ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Ex vivo; Human tumor specimens; Immunohistochemistry; Preclinical model; Replication selective; Viral localization

Indexed keywords

ONCOLYTIC VIRUS;

ADENOVIRUS; ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CELL SURVIVAL; CYTOPATHOGENIC EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METASTASIS; METHODOLOGY; MOUSE; NEOPLASM; ONCOLYTIC VIROTHERAPY; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYTOPATHOGENIC EFFECT, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

ANIMALIA;

EID: 80555127420     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-340-0_5     Document Type: Chapter

References (16)

1. Parato, K. A., Senger, D., Forsyth, P. A., and Bell, J. C. (2005) Recent progress in the battle between oncolytic viruses and tumours, Nat Rev Cancer 5, 965–976.
2. Liu, T. C., Galanis, E., and Kirn, D. (2007) Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress, Nat Clin Pract Oncol 4, 101–117.
3. de Vrij, J., Willemsen, R. A., Lindholm, L., and Hoeben, R. C., GIANT consortium (2010) Adenovirus-Derived Vectors for Prostate Cancer Gene Therapy, Hum Gene Ther 21(7), 795–805.
4. Matthews, K., Noker, P. E., Tian, B., Grimes, S. D., Fulton, R., Schweikart, K., Harris, R., Aurigemma, R., Wang, M., Barnes, M. N., Siegal, G. P., Hemminki, A., Zinn, K., Curiel, D. T., and Alvarez, R. D. (2009) Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer, Clin Cancer Res 15, 4131–4137.
5. Freytag, S. O., Stricker, H., Peabody, J., Pegg, J., Paielli, D., Movsas, B., Barton, K. N., Brown, S. L., Lu, M., and Kim, J. H. (2007) Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer, Mol Ther 15, 636–642.
6. Öberg, D., Yanover, E., Sweeney, K., Adam, V., Costas, C., Lemoine, N.R., and Halldén, G. (2010) Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant (AdΔΔ) in prostate and pancreatic cancers. Clin Canc Res 16, 541–53.
7. Russell, W. C. (2009) Adenoviruses: update on structure and function, J Gen Virol 90, 1–20.
8. Thomas, M. A., Spencer, J. F., Toth, K., Sagartz, J. E., Phillips, N. J., and Wold, W. S. (2008) Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model, Mol Ther 16, 1665–1673.
9. Thomas, M. A., Spencer, J. F., and Wold, W. S. (2007) Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors, Methods Mol Med 130, 169–183.
10. Steel, J. C., Morrison, B. J., Mannan, P., Abu-Asab, M. S., Wildner, O., Miles, B. K., Yim, K. C., Ramanan, V., Prince, G. A., and Morris, J. C. (2007) Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus, Virology 369, 131–142.
11. Wang, Y., Hallden, G., Hill, R., Anand, A., Liu, T. C., Francis, J., Brooks, G., Lemoine, N., and Kirn, D. (2003) E3 gene manipulations affect oncolytic adenovirus activity in immuno- competent tumor models, Nat Biotechnol 21, 1328–1335.
12. Kasuya, H., Pawlik, T. M., Mullen, J. T., Donahue, J. M., Nakamura, H., Chandrasekhar, S., Kawasaki, H., Choi, E., and Tanabe, K. K. (2004) Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen, Cancer Res 64, 2561–2567.
13. Kirby, T. O., Rivera, A., Rein, D., Wang, M., Ulasov, I., Breidenbach, M., Kataram, M., Contreras, J. L., Krumdieck, C., Yamamoto, M., Rots, M. G., Haisma, H. J., Alvarez, R. D., Mahasreshti, P. J., and Curiel, D. T. (2004) A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity, Clin Cancer Res 10, 8697–8703.
14. Marsman, W. A., Buskens, C. J., Wesseling, J. G., Offerhaus, G. J., Bergman, J. J., Tytgat, G. N., van Lanschot, J. J., and Bosma, P. J. (2004) Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo, Cancer Gene Ther 11, 289–296.
15. Wang, Y., Thorne, S., Hannock, J., Francis, J., Au, T., Reid, T., Lemoine, N., Kirn, D., and Hallden, G. (2005) A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenoviruses, Clin Cancer Res 11, 351–360.
16. O’Reilly, D., Muller, L., and Luckow, V. (1994) Virus Methods, in Bculovirus expression vectors: A laboratory manual, pp 132–134, Oxford University Press, Oxford.